Analysis of Substance Abuse
<iframe height=’530′ frameborder=’0′ style=’border:1px solid #ddd;’ width=’660′ src=’https://fod.infobase.com/OnDemandEmbed.aspx?token=49964&wID=100753&plt=FOD&loid=0&w=640&h=480&fWidth=660&fHeight=530′ allowfullscreen allow=”encrypted-media”> </iframe>
<iframe height=’530′ frameborder=’0′ style=’border:1px solid #ddd;’ width=’660′ src=’https://fod.infobase.com/OnDemandEmbed.aspx?token=44908&wID=100753&plt=FOD&loid=0&w=640&h=480&fWidth=660&fHeight=530′ allowfullscreen allow=”encrypted-media”> </iframe>
In keeping with the focus of this class, the emphasis of your paper should be on the neuroscience aspects of the disorder you selected. In your paper, please be sure that the following aspects of your topic are discussed:
Explain the theories of etiology (causes) with a focus on the neurobiology of the disorder.
Explain associated factors in the development of the disorder (genetic, environmental, familial, lifestyle).
Describe the pathology of the disorder with an emphasis on the abnormalities of nervous system structure and function, including any genetic and biochemical aspects.
Give examples of treatment options, including both drug (pharmacological) and non-drug (nonpharmacological treatments), with rationales for use of these treatments based on current understanding of the neurobiology of the disorder.
Summarize diagnostic and research technologies employed in clinical diagnosis, clinical and behavioral health care, and basic science research.
Choose any of these sources to reference:
CDC. (2018). Understanding the Epidemic | Drug Overdose | CDC Injury Center. Retrieved 16 March 2021, from https://www.cdc.gov/drugoverdose/epidemic/index.html
Ashok, A., Mizuno, Y., & Howes, O. (2019). Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies. Psychopharmacology, 236(4), 1119-1129. doi: 10.1007/s00213-019-05196-1
Chouhan, D., Uniyal, A., Gadepalli, A., Akhilesh, Tiwari, V., & Agrawal, S. et al. (2020). Probing the Manipulated Neurochemical Drive in Alcohol Addiction and Novel Therapeutic Advancements. ACS Chemical Neuroscience, 11(9), 1210-1217. doi: 10.1021/acschemneuro.0c00073
You may add any additional sources that are 5 years old or newer.